New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
06:36 EDTNCSNCI Building Systems initiated with a Buy at BB&T
Target $20.
News For NCS From The Last 14 Days
Check below for free stories on NCS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2013
18:52 EDTNCSOn The Fly: After Hours Movers
UP AFTER EARNINGS: Hewlett-Packard (HPQ), up 13.4% after reporting second quarter earnings that beat expectations and guiding third quarter and full-year earnings above estimates... Pacific Sunwear (PSUN), up 14.3%. ALSO HIGHER: Merck (MRK), up 0.2% after an FDA advisory panel voted 13-3 in support of the safety of initial doses of its insomnia drug suvorexant. DOWN AFTER EARNINGS: DryShips (DRYS), down 4.7%. ALSO LOWER: Apricus Biosciences (APRI), down 11.5% after filing to sell an ungiven amount of stock... NCI Building Systems (NCS) after being replaced by Cynosure (CYNO) in the S&P 600 as of May 31.
17:24 EDTNCSCynosure to replace NCI Building Systems in S&P 600 as of May 31
NCI Building Systems announced the conversion of some preferred stock which will leave the company’s public float substantially below the 50% threshold needed for continued inclusion in the index.
May 14, 2013
18:48 EDTNCSNCI Building Systems has replay of business news update conference call
Subscribe for More Information
16:07 EDTNCSNCI Building Systems announces conversion of preffereds to common shares
NCI Building Systems announced that the holders of the company's preferred shares have delivered formal notice that they will convert all of their preferred shares to common shares. The conversion will eliminate all outstanding convertible preferred stock beginning in Q3. In conjunction with the conversion of its convertible preferred stock, the company also announced it will seek to refinance its existing $240M term loan.
16:05 EDTNCSNCI Building Systems expects Q2 loss per share, consensus (5c)
Sees Q2 revenue $293M, consensus $310.32M. Sees Q2 adjusted EBITDA $10M-$11M.

Sign up for a free trial to see the rest of the stories you've been missing.